| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.92B | 101.01B | 92.33B | 94.51B | 76.09B | 62.85B |
| Gross Profit | 22.40B | 21.26B | 17.37B | 18.76B | 17.67B | 14.65B |
| EBITDA | 5.22B | 4.91B | 2.63B | 4.18B | 5.43B | 3.93B |
| Net Income | 791.00M | 763.00M | -1.16B | 885.73M | 1.75B | 1.09B |
Balance Sheet | ||||||
| Total Assets | 101.00B | 100.04B | 98.58B | 92.44B | 78.91B | 69.39B |
| Cash, Cash Equivalents and Short-Term Investments | 4.93B | 4.75B | 6.85B | 6.30B | 6.63B | 3.48B |
| Total Debt | 42.03B | 42.56B | 39.37B | 33.67B | 21.50B | 17.68B |
| Total Liabilities | 64.06B | 62.03B | 57.70B | 51.62B | 38.80B | 31.95B |
| Stockholders Equity | 36.27B | 37.33B | 37.22B | 37.10B | 36.74B | 34.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 684.00M | -2.94B | -3.99B | 243.85M | 781.36M |
| Operating Cash Flow | 0.00 | 6.14B | 353.00M | -466.24M | 2.83B | 3.01B |
| Investing Cash Flow | 0.00 | -4.98B | -3.20B | -6.65B | -3.44B | -1.86B |
| Financing Cash Flow | 0.00 | -3.67B | 2.90B | 7.66B | 2.11B | -1.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥34.73B | 9.15 | ― | 2.47% | 3.53% | 8.36% | |
77 Outperform | ¥26.90B | 6.28 | ― | 3.63% | 18.02% | 18.04% | |
76 Outperform | ¥26.20B | 6.46 | ― | 3.21% | 9.61% | 173.72% | |
72 Outperform | ¥26.24B | 12.16 | ― | 3.84% | -3.41% | -12.83% | |
66 Neutral | ¥23.56B | 5.80 | ― | 4.62% | 7.19% | ― | |
62 Neutral | ¥25.75B | 9.97 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |